Korean J Gastroenterol.  2013 Jun;61(6):303-306. 10.4166/kjg.2013.61.6.303.

Role of 18F 2-fluoro-2-deoxyglucose Positron Emission Tomography in Upper Gastrointestinal Malignancies

Affiliations
  • 1Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea. shimkn@ewha.ac.kr

Abstract

The 18F 2-fluoro-2-deoxyglucose (FDG) PET/CT scan is an imaging modality used in the management of patients with various types of malignancies. 18F-FDG PET/CT has demonstrated significant efficacy in the staging and detection of metastatic disease in malignancies of the gastrointestinal tract. The assessment of the metabolic response to chemotherapy and improvements of overall survivals in malignancies of esophagus and stomach has been demonstrated in several studies. This review focuses on the role of 18F-FDG PET/CT scan in staging, metastasis, predict of recurrence and assessment of metabolic response in malignancies of the upper gastrointestinal tract.

Keyword

Positron emission tomography and computed tomography; Upper gastrointestinal tract; Esophageal cancer; Stomach cancer

MeSH Terms

Esophageal Neoplasms/pathology/*radionuclide imaging
Fluorodeoxyglucose F18/diagnostic use
Humans
Lymphatic Metastasis
Neoplasm Metastasis
Neoplasm Staging
Positron-Emission Tomography
Radiopharmaceuticals/diagnostic use
Recurrence
Stomach Neoplasms/pathology/*radionuclide imaging
Fluorodeoxyglucose F18
Radiopharmaceuticals
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr